Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 350

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 350
---
               |
|:----------------------------|:----|:-------|-----------:|:--|:----|:-------|------------:|:--|:----|:-------|------------:|:--|:----|:-------|------------:|:--|:----|:-------|------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|:----|:-------|--------------:|
| Gross Sales(1)              |     | $      |          — |   |     | $      |           — |   |     | $      |           — |   |     | $      |  55,772,493 |   |     | $      | 449,647,912 |     | $      | 1,561,901,414 |     | $      | 4,062,790,900 |     | $      | 4,875,632,300 |     | $      | 5,141,859,100 |     | $      | 5,331,616,500 |
| Cost of Sales(2)            |     | $      |          — |   |     | $      |           — |   |     | $      |           — |   |     | $      |   5,577,249 |   |     | $      |  44,964,791 |     | $      |   156,190,141 |     | $      |   406,279,090 |     | $      |   487,563,230 |     | $      |   514,185,910 |     | $      |   533,161,501 |
| Gross Profit(3)             |     | $      |          — |   |     | $      |           — |   |     | $      |           — |   |     | $      | (26,512,910 | ) |     | $      | 214,600,284 |     | $      |   522,122,880 |     | $      | 2,168,514,643 |     | $      | 2,602,368,740 |     | $      | 2,744,467,295 |     | $      | 2,845,750,307 |
| Total Operating Expenses